Long on $WORK.
Solid resistance at the $24 level. Tested multiple times.
Like that it rose sharply recently due to increase demand from COVID-19 forced remote work.
Good entry point at this pull back. Stop is $21.5 with profit target at the high of the consolidation trend @ $32.
P/L ratio ~ 3:1.
Solid retail company -- fourth quarter earnings crushed analysts' estimates and has refocused business plan to compete against Amazon.
Also forming ascending triangle pattern.
Look for the break over $63.00
Reported solid phase 1 and phase 2 results for its drug Bempedoic Acid.
Amgen is soon releasing results from a similar drug; if results are promising, $ESPR could trend up.
Also forming cup and handle pattern.